Figure 1From: Impact of UGT2B7 His268Tyr polymorphism on the outcome of adjuvant epirubicin treatment in breast cancerPatient flow chart based on the original TIGER cohort. AI, aromatase inhibitor, TIGER, Austrian tumor of breast tissue: incidence, genetics, and environmental risk factors study.Back to article page